» Articles » PMID: 22155462

No Relationship Between Vitamin D Status and Insulin Resistance in a Group of High School Students

Overview
Date 2011 Dec 14
PMID 22155462
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the effects of vitamin D deficiency on both insulin resistance and risk of metabolic syndrome in children.

Methods: The study group consisted of 301 children and adolescents with a mean age of 14.2 ± 1.8 years. Serum 25-hydroxyvitamin D [25(OH)D] levels and insulin resistance indices were evaluated. According to serum 25(OH)D levels, the subjects were classified in 3 groups. Those with levels ≤ 10 ng/mL were labeled as the vitamin D deficient group (group A), those with levels of 10-20 ng/mL as the vitamin D insufficient group (group B) and those with ≥ 20 ng/mL as having normal vitamin D levels (group C). Metabolic syndrome was defined according to the International Diabetes Federation consensus. The participants with and without metabolic syndrome were compared in terms of 25(OH)D levels.

Results: Mean 25(OH)D level of the total group was 18.2 ± 9.3 (2.8-72.0) ng/mL. Distribution of individuals according to their vitamin D levels showed that 11.6% were in group A, 53.5% in group B, and 34.9% in group C. The proportions of boys and girls in these categories were 22.9% and 77.1% in group A, 36.6% and 63.4% in group B, 54.3% and 45.7% in group C, respectively. There were no significant differences in 25(OH)D levels in the individuals with and without impaired fasting glucose or impaired glucose tolerance. No relationship was observed between insulin resistance/sensitivity indices and vitamin D status (p > 0.05). Metabolic syndrome was diagnosed in 12.3% (n = 37) of the children. There was also no difference in mean 25(OH)D levels between individuals who had and those who did not have the metabolic syndrome.

Conclusion: In our study, no correlations were found between insulin measurements during oral glucose tolerance test and vitamin D deficiency. Nonetheless, more extended studies including vitamin D supplementation and evaluating insulin sensitivity via clamp technique are needed to further elucidate this relationship.

Citing Articles

The Relationship between Anthropometric Measurements and Vitamin D Levels and Insulin Resistance in Obese Children and Adolescents.

Cigri E, Inan F Children (Basel). 2022; 9(12).

PMID: 36553281 PMC: 9776708. DOI: 10.3390/children9121837.


A cross-sectional study on the effect of dietary zinc intake on the relationship between serum vitamin D and HOMA-IR.

Hu B, Lin Z, Cai Y, Sun Y, Yang S, Guo J Front Nutr. 2022; 9:945811.

PMID: 36352900 PMC: 9638013. DOI: 10.3389/fnut.2022.945811.


Vitamin D, body mass composition and metabolic risk factors in healthy young Indians.

Menon A, Kapoor R, Anayath S, Garg M Med J Armed Forces India. 2021; 77(4):485-489.

PMID: 34594080 PMC: 8459086. DOI: 10.1016/j.mjafi.2020.05.011.


Vitamin D status and cardiometabolic risk factors in Greek adolescents with obesity - the effect of vitamin D supplementation: a pilot study.

Makariou S, Challa A, Siomou E, Tellis C, Tselepis A, Elisaf M Arch Med Sci Atheroscler Dis. 2020; 5:e64-e71.

PMID: 32529108 PMC: 7277522. DOI: 10.5114/amsad.2020.95569.


Association of Vitamin D Status and Metabolic Syndrome Components in Iranian Children.

Ghobadi S, Rostami Z, Marzijarani M, Faghih S Int J Prev Med. 2019; 10:77.

PMID: 31198512 PMC: 6547802. DOI: 10.4103/ijpvm.IJPVM_242_17.


References
1.
Gulseth H, Gjelstad I, Tierney A, Lovegrove J, Defoort C, Blaak E . Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care. 2010; 33(4):923-5. PMC: 2845053. DOI: 10.2337/dc09-1692. View

2.
Binkley N, Ramamurthy R, Krueger D . Low vitamin D status: definition, prevalence, consequences, and correction. Endocrinol Metab Clin North Am. 2010; 39(2):287-301, table of contents. PMC: 4315502. DOI: 10.1016/j.ecl.2010.02.008. View

3.
Rigby W, Denome S, Fanger M . Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest. 1987; 79(6):1659-64. PMC: 424495. DOI: 10.1172/JCI113004. View

4.
Bikle D . Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2008; 94(1):26-34. PMC: 2630868. DOI: 10.1210/jc.2008-1454. View

5.
Demay M, Sabbagh Y, Carpenter T . Calcium and vitamin D: what is known about the effects on growing bone. Pediatrics. 2007; 119 Suppl 2:S141-4. DOI: 10.1542/peds.2006-2023F. View